‘Unsettling to American partners’: Trump’s offer to sell arms to China is an admission he doesn’t take its security threats seriously, experts warn

President Trump reportedly offered to sell weapons to China during Xi Jinping’s Washington summit, despite the White House stating that no such arms sale is planned. The proposal clashes with U.S. sanctions and export restrictions on China and comes while the administration is withholding a $14 billion Taiwan arms package, drawing concern over U.S. deterrence and alliance commitments. The article also highlights Trump’s transactional approach, including an exception allowing Nvidia and AMD chip sales to China under a U.S. revenue-sharing arrangement of up to 25%.

Analysis

The investable signal is not a literal defense sale to China—which lacks a credible authorization path—but a higher policy-discretion premium across China-exposed semiconductors. NVDA and AMD can benefit if commercial concessions broaden the set of exportable accelerators or raise permissible volumes, yet that upside should not receive a full multiple re-rating: each concession simultaneously increases the probability of abrupt reversals, congressional intervention, and tighter allied controls. Over the next 1-3 months, licensing decisions, product-specific performance thresholds, and any disclosed government revenue-sharing terms matter far more than summit rhetoric.

The underappreciated second-order risk is Taiwan deterrence rather than bilateral chip trade. Delays in Taiwan defense procurement would raise the perceived probability of supply disruption at TSMC, affecting the entire fabless stack—NVDA, AMD, AVGO, QCOM and AAPL—while benefiting defense primes only once orders are actually released. A rising Taiwan-risk premium would likely first show up in TSMC ADR relative underperformance, higher semiconductor implied volatility, and a widening gap between US defense primes (LMT, RTX, NOC) and broad industrials; this is a 6-18 month structural risk, not necessarily an immediate earnings event.

Contrarian view: markets may initially treat any China access concession as unambiguously bullish for NVDA/AMD. The more durable consequence could be lower valuation multiples if investors conclude China revenue is becoming a negotiated, revocable political asset rather than a dependable end-market. FOX has no direct fundamental read-through beyond potentially elevated event-driven audience and advertising volatility; there is no clean equity trade from the disclosure itself.

Key Decisions for Investors

• Maintain only tactical, hedged China-revenue exposure in NVDA and AMD over the next 1-3 months: pair long NVDA or AMD against short SMH only if a verifiable license expansion or China-specific shipment guidance emerges. Target 10-15% upside on an earnings-revision catalyst; exit if export-license terms are narrowed, delayed, or accompanied by bipartisan legislative opposition.
• Establish a watch trigger—not an immediate position—in TSM versus SMH: initiate long TSM / short SMH only if Taiwan-related defense approvals resume and TSM's relative performance confirms. Conversely, a further procurement delay plus TSM underperformance would support a defensive semiconductor hedge via SMH puts, given concentrated Taiwan manufacturing exposure.
• Use LMT, RTX, and NOC as an event-driven basket rather than pricing in a Taiwan order acceleration today. Buy on confirmed contract awards or formal notification milestones, not political letters; a 6-12 month order-book catalyst can support the trade, while continued deferral or substitution toward asymmetric systems falsifies the thesis.
• Avoid FOX as a geopolitical-expression trade. Reassess only if sustained election or foreign-policy coverage produces a measurable improvement in affiliate-fee leverage, advertising demand, or forward guidance; absent that evidence, the fundamental impact is immaterial.